Histone deacetylases (HDACs) as the promising immunotherapeutic targets for hematologic cancer treatment

FF Yang, T Hu, JQ Liu, XQ Yu, LY Ma - European Journal of Medicinal …, 2023 - Elsevier
Bone marrow transplantation is regarded as the most effective immunotherapy for
hematologic cancer, but it generally faces difficulties in matching. Aberrant expression of …

[HTML][HTML] Tackling triple negative breast cancer with HDAC inhibitors: 6 is the isoform!

A Guadagni, S Barone, AI Alfano, S Pelliccia… - European Journal of …, 2024 - Elsevier
Triple negative breast cancer (TNBC) is a highly aggressive breast cancer subtype
characterized by the lack in the expression of estrogen and progesterone receptors, and …

Identification of novel natural dual HDAC and Hsp90 inhibitors for metastatic TNBC using e-pharmacophore modeling, molecular docking, and molecular dynamics …

N AbdElmoniem, M H. Abdallah, R M. Mukhtar… - Molecules, 2023 - mdpi.com
Breast cancer (BC) is one of the main types of cancer that endangers women's lives. The
characteristics of triple-negative breast cancer (TNBC) include a high rate of recurrence and …

Discovery of novel inhibitors of histone deacetylase 6: Structure-based virtual screening, molecular dynamics simulation, enzyme inhibition and cell viability assays

AI Uba, M Hryb, M Singh, C Bui-Linh, A Tran, J Atienza… - Life Sciences, 2024 - Elsevier
Abstract Histone deacetylase 6 (HDAC6) contributes to cancer metastasis in several
cancers, including triple-negative breast cancer (TNBC)—the most lethal form that lacks …

First-in-class dual mechanism ferroptosis-HDAC inhibitor hybrids

E Karaj, SH Sindi, N Kuganesan… - Journal of medicinal …, 2022 - ACS Publications
HDAC inhibitors are an attractive class of cytotoxic agents for the design of hybrid
molecules. Several HDAC hybrids have emerged over the years, but none combines HDAC …

Programming a Ferroptosis‐to‐Apoptosis Transition Landscape Revealed Ferroptosis Biomarkers and Repressors for Cancer Therapy

Y Vinik, A Maimon, V Dubey, H Raj… - Advanced …, 2024 - Wiley Online Library
Ferroptosis and apoptosis are key cell‐death pathways implicated in several human
diseases including cancer. Ferroptosis is driven by iron‐dependent lipid peroxidation and …

Epigenetic oncogenesis, biomarkers and emerging chemotherapeutics for breast cancer

YO Ayipo, AT Ajiboye, WA Osunniran, AA Jimoh… - … et Biophysica Acta (BBA …, 2022 - Elsevier
Breast cancer remains one of the leading causes of cancer-related deaths globally and the
most prominent among females, yet with limited effective therapeutic options. Most of the …

Exploring the role of metabolites in cancer and the associated nerve crosstalk

I Gu, E Gregory, C Atwood, SO Lee, YH Song - Nutrients, 2022 - mdpi.com
Since Otto Warburg's first report on the increased uptake of glucose and lactate release by
cancer cells, dysregulated metabolism has been acknowledged as a hallmark of cancer that …

Impact of HDAC6-mediated progesterone receptor expression on the response of breast cancer cells to hormonal therapy

WS Ramadan, RK Alseksek, S Mouffak… - European Journal of …, 2024 - Elsevier
Modulation of estrogen receptor (ER) and progesterone receptor (PR) expression, as well as
their emerging functional crosstalk, remains a potential approach for enhancing the …

Protein kinase C at the crossroad of mutations, cancer, targeted therapy and immune response

A Aquino, N Bianchi, A Terrazzan, O Franzese - Biology, 2023 - mdpi.com
Simple Summary This review aims to analyze the clinical drawbacks faced by PKC inhibitors
and uncovering aspects that might potentially interfere with the clinical outcome of …